Indivior PLC

Indivior PLC is a global pharmaceutical company specializing in addiction treatment and mental health. The company focuses on developing, manufacturing, and commercializing medicines to address substance use disorders, including opioid addiction. Indivior's portfolio includes both established and innovative therapies aimed at helping individuals and communities affected by addiction. Through research and development, the company strives to advance treatment options and improve patient outcomes. Indivior operates within the healthcare sector, contributing to the global effort to combat addiction and promote mental well-being. The company's commitment extends to supporting healthcare professionals and advocating for policies that improve access to evidence-based addiction treatment.